Kim S, Shin D, Ham H, Kim Y, Gu Y, Kim H
JAMA Netw Open. 2025; 8(3):e250096.
PMID: 40042844
PMC: 11883494.
DOI: 10.1001/jamanetworkopen.2025.0096.
Li C, Fan L, Lin C, Hu C, Chiu M
ACS Omega. 2025; 10(7):7256-7263.
PMID: 40028141
PMC: 11865983.
DOI: 10.1021/acsomega.4c10879.
Lin J, El Helwe H, Falah H, Hammerschlag B, Schultz S, Baldwin G
Transl Vis Sci Technol. 2025; 14(2):24.
PMID: 39998458
PMC: 11875033.
DOI: 10.1167/tvst.14.2.24.
Salari A, Camacho Valenzuela J, Le N, Dahmer J, Sklavounos A, Kan C
Lab Chip. 2025; .
PMID: 39991902
PMC: 11849296.
DOI: 10.1039/d4lc01002g.
Liu B, Shen J, Li J, Tian B, Zhou B, Gui J
Front Immunol. 2025; 16:1468665.
PMID: 39981245
PMC: 11839629.
DOI: 10.3389/fimmu.2025.1468665.
Implantable photoelectrochemical-therapeutic methotrexate monitoring system with dual-atomic docking strategy.
Xu X, Xu D, Zhou X, Huang J, Gu S, Zhang Z
Nat Commun. 2025; 16(1):1747.
PMID: 39966460
PMC: 11836052.
DOI: 10.1038/s41467-025-57084-2.
Prediction of cognitive conversion within the Alzheimer's disease continuum using deep learning.
Yang S, Zhang X, Du X, Yan P, Zhang J, Wang W
Alzheimers Res Ther. 2025; 17(1):41.
PMID: 39948600
PMC: 11823042.
DOI: 10.1186/s13195-025-01686-x.
Introducing AVAC as an ultra-sensitive platform with broad dynamical range for high-throughput multiplexed biomarker detection using digital counting of plasmonic nanoparticles.
Cebrian V, Pini V, Thon A, Marina-Garcia N, Salvador-Matar A, Rodriguez C
Sci Rep. 2025; 15(1):5390.
PMID: 39948115
PMC: 11825739.
DOI: 10.1038/s41598-025-88992-4.
Plasma Phosphorylated Tau 217 as a Discriminative Biomarker for Cerebral Amyloid Angiopathy.
Hsieh P, Tsai H, Liu C, Lee B, Tsai Y, Yen R
Eur J Neurol. 2025; 32(2):e70066.
PMID: 39907306
PMC: 11795418.
DOI: 10.1111/ene.70066.
NAPTUNE: nucleic acids and protein biomarkers testing via ultra-sensitive nucleases escalation.
Hu T, Ke X, Yu Y, Feng H, Zhang S, Cui Y
Nat Commun. 2025; 16(1):1331.
PMID: 39900931
PMC: 11790866.
DOI: 10.1038/s41467-025-56653-9.
Productive biosensing techniques empowered by all-dielectric metasurfaces.
Iwanaga M
Front Bioeng Biotechnol. 2025; 12:1484638.
PMID: 39872468
PMC: 11770831.
DOI: 10.3389/fbioe.2024.1484638.
The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
Samadzadeh S, Sleator R
eNeurologicalSci. 2025; 38:100550.
PMID: 39866832
PMC: 11762903.
DOI: 10.1016/j.ensci.2025.100550.
Polygenic risk discriminates Lewy body dementia from Alzheimer's disease.
McKeever A, Swann P, Malpetti M, Donaghy P, Thomas A, Mak E
Alzheimers Dement. 2025; 21(2):e14381.
PMID: 39853853
PMC: 11848393.
DOI: 10.1002/alz.14381.
Plasmonic Single-Molecule Affinity Detection at 10 Molar.
Macchia E, Franco C, Scandurra C, Sarcina L, Piscitelli M, Catacchio M
Adv Mater. 2025; 37(9):e2418610.
PMID: 39846333
PMC: 11881672.
DOI: 10.1002/adma.202418610.
A blood test for Alzheimer's disease: a decade of progress and success.
Ashton N, Zetterberg H
EBioMedicine. 2025; 112:105545.
PMID: 39778288
PMC: 11761914.
DOI: 10.1016/j.ebiom.2024.105545.
Advances in subpopulation separation and detection of extracellular vesicles: for liquid biopsy and downstream research.
Liu Z, Chen G, Yu Z
Theranostics. 2025; 15(3):1135-1155.
PMID: 39776815
PMC: 11700854.
DOI: 10.7150/thno.106459.
Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer's disease biomarkers.
Wojdala A, Bellomo G, Gaetani L, Teunissen C, Parnetti L, Chiasserini D
Nat Commun. 2025; 16(1):214.
PMID: 39747866
PMC: 11696609.
DOI: 10.1038/s41467-024-54878-8.
Nanotechnology for the Diagnosis and Treatment of Liver Cancer.
Cai Y, Wang W, Jiao Q, Hu T, Ren Y, Su X
Int J Nanomedicine. 2024; 19:13805-13821.
PMID: 39735328
PMC: 11681781.
DOI: 10.2147/IJN.S490661.
How Highly Heterogeneous Sensors with Single-Molecule Resolution can Result in Robust Continuous Monitoring Over Long Time Spans.
Vu C, Yan J, de Jong A, Prins M
Adv Sci (Weinh). 2024; 12(7):e2412181.
PMID: 39716982
PMC: 11831471.
DOI: 10.1002/advs.202412181.
Retinal Microperimetry as a Novel Tool for Early Detection of Subclinical Cognitive Dysfunction and Brain Damage in Type 1 Diabetes: A Pilot Study.
Mateu-Salat M, Stanton-Yonge N, Santalo F, Vela J, Cascajosa J, Perez E
Endocrinol Diabetes Metab. 2024; 8(1):e70018.
PMID: 39707866
PMC: 11662260.
DOI: 10.1002/edm2.70018.